Literature DB >> 12185589

pRb2/p130 promotes radiation-induced cell death in the glioblastoma cell line HJC12 by p73 upregulation and Bcl-2 downregulation.

Bruna Pucci1, Pier Paolo Claudio, Valeria Masciullo, Lorenza Bellincampi, Alessandro Terrinoni, Kamel Khalili, Gerry Melino, Antonio Giordano.   

Abstract

This study shows that in the glioblastoma hamster cell line HJC12 the retinoblastoma family member pRb2/p130 enhances gamma-radiation-induced cell death. In HJC12 cells the tetracycline-regulated expression of pRb2/p130 increased the percentage of gamma-radiation-induced apoptotic cells from 27 to 47%. pRb2/p130 overexpression was associated with the downregulation of the anti-apoptotic factor Bcl-2 and the upregulation of the steady-state protein levels of the pro-apoptotic transcription factor p73. In particular, RT-PCR showed a significant increase in the expression of the p73delta isoform when pRb2/p130 was overexpressed. The ability of pRb2/p130 to modulate apoptosis was not associated with its role in mediating G0/G1 arrest during cell cycle progression. Our data suggest a role for pRb2/p130 in glioblastoma gamma-radiation-induced cell death, indicating that the antitumoral action of pRb2/p130 can regulate both inhibition of cell cycle progression and induction of cell death.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12185589     DOI: 10.1038/sj.onc.1205750

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Cross-talk between T-Ag presence and pRb family and p53/p73 signaling in mouse and human medulloblastoma.

Authors:  Valentina Caracciolo; Marcella Macaluso; Luca D'Agostino; Micaela Montanari; Jonathan Scheff; Krzysztof Reiss; Kamel Khalili; Antonio Giordano
Journal:  J Cell Biochem       Date:  2010-05       Impact factor: 4.429

2.  RB goes mitochondrial.

Authors:  Laura D Attardi; Julien Sage
Journal:  Genes Dev       Date:  2013-05-01       Impact factor: 11.361

3.  Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer.

Authors:  Jikai Yin; Charles Lu; Jian Gu; Scott M Lippman; Michelle A T Hildebrandt; Jie Lin; David Stewart; Margaret R Spitz; Xifeng Wu
Journal:  Carcinogenesis       Date:  2011-09-28       Impact factor: 4.944

Review 4.  Medulloblastoma: from molecular pathology to therapy.

Authors:  Alessandra Rossi; Valentina Caracciolo; Giuseppe Russo; Krzysztof Reiss; Antonio Giordano
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

5.  RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines.

Authors:  Francesca Pentimalli; Iris M Forte; Luca Esposito; Paola Indovina; Carmelina A Iannuzzi; Luigi Alfano; Caterina Costa; Daniela Barone; Gaetano Rocco; Antonio Giordano
Journal:  Oncogene       Date:  2018-04-02       Impact factor: 9.867

Review 6.  RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy.

Authors:  Paola Indovina; Francesca Pentimalli; Nadia Casini; Immacolata Vocca; Antonio Giordano
Journal:  Oncotarget       Date:  2015-07-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.